Melanocytic Neoplasms I: Molecular Diagnosis-Reference-Cited by-同舟云学术

Melanocytic Neoplasms I: Molecular Diagnosis

Published:2011 Issue: Volume: Page:73-103
ISSN:
Container-title:Molecular Diagnostics in Dermatology and Dermatopathology
language:
Short-container-title:

Author:

Gerami Pedram,Gammon Bryan,Murphy Michael J.

Publisher

Humana Press

Link

http://link.springer.com/content/pdf/10.1007/978-1-60761-171-4_5.pdf

Reference170 articles.

1. American Cancer Society. Available at http://www.cancer.org/Cancer/SkinCancer-Melanoma/DetailedGuide/melanoma-skin-cancer-key-statistics . Accessed 24 Augt 2010.

2. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353:2135–47.

3. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949–54.

4. Pollock PM, Harper UL, Hansen KS, et al. High frequency of BRAF mutations in nevi. Nat Genet. 2003;33:19–20.

5. Da Forno PD, Fletcher A, Pringle JH, et al. Understanding spitzoid tumours: new insights from molecular pathology. Br J Dermatol. 2008;158:4–14.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased frequency of minimal homozygous deletions is associated with poor prognosis in primary malignant melanoma patients;Genes, Chromosomes and Cancer;2014-02-24

2. Molecular Platforms Utilized to Detect BRAF V600E Mutation in Melanoma;Seminars in Cutaneous Medicine and Surgery;2012-12

3. Molecular diagnostic strategies: a role in the practice of dermatology;International Journal of Dermatology;2012-10-16

4. Introduction to Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma;Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma;2011-11-18